abstract |
The present invention relates to providing an ophthalmic composition suitable for guided injection. The composition comprises an amount of a complexing agent that forms a mass with enhanced viscosity by reacting with one or more endogenous components (e.g., hyaluronic acid) in the eye. This mass can help to produce the desired release characteristics of the therapeutic agent. |